This review describes the complex interplay between inflammation, vasculopathy and
fibrosis that involve the heart and peripheral small vessels, leading to endothelial stiffness …

The prevalence of auto-antibodies associated to pulmonary arterial hypertension in
scleroderma patients was reviewed, based on reports cited in two major scientific …

Objectives To examine the prevalence and associated factors related to the coexistence of
antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) in a cohort of …

Objective To evaluate the clinical relevance of antiphospholipid antibodies (aPL) in systemic
sclerosis (SSc). Methods A systematic search of EMBASE and PubMed databases from …

Background The diagnosis of antiphospholipid syndrome (APS) requires the presence of
thrombosis and/or recurrent miscarriages along with one or more anti-phospholipid …

Objectives: Antiphospholipid antibodies (aPL) can be present in the sera of systemic
sclerosis (SSc) patients. This study aimed to determine the prevalence of aPL in a cross …

Aim To evaluate the clinical and antibody profile of systemic sclerosis (SS c) in a Malaysian
cohort. Methods Consecutive patients with SS c in U niversity M alaya M edical C entre from …

Antiphospholipid (aPL) autoantibodies are uncommon in systemic autoimmune diseases
(SADs). However, the European PRECISESADS study provides the opportunity to better …

Background. Several chronic inflammatory disorders, such as rheumatoid arthritis,
inflammatory myositis, and systemic vasculitides, have been linked to an increased risk of …

Antiphospholipid syndrome (APS) is an acquired prothrombotic condition characterized by
vascular thrombosis and/or obstetric complications, in the persistent positivity of circulating …